David Sinclair· PhD
Originally the FDA banned the sale of NMN in 2022 because it is being developed as a medicine by Metrobiotech, a company I founded
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Originally the FDA banned the sale of NMN in 2022 because it is being developed as a medicine by Metrobiotech, a company I founded
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I do not control Metrobiotech and did not advocate for the ban.